PL2882446T3 - Terapia profilaktyczna i nutraceutyczna - Google Patents

Terapia profilaktyczna i nutraceutyczna

Info

Publication number
PL2882446T3
PL2882446T3 PL13762204T PL13762204T PL2882446T3 PL 2882446 T3 PL2882446 T3 PL 2882446T3 PL 13762204 T PL13762204 T PL 13762204T PL 13762204 T PL13762204 T PL 13762204T PL 2882446 T3 PL2882446 T3 PL 2882446T3
Authority
PL
Poland
Prior art keywords
prophylactic
nutraceutical therapy
nutraceutical
therapy
Prior art date
Application number
PL13762204T
Other languages
English (en)
Inventor
Catharina Svanborg
Manoj PUTHIA
Chin Shing HO
Original Assignee
Hamlet Pharma Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1214234.5A external-priority patent/GB201214234D0/en
Priority claimed from GBGB1214237.8A external-priority patent/GB201214237D0/en
Application filed by Hamlet Pharma Ab filed Critical Hamlet Pharma Ab
Publication of PL2882446T3 publication Critical patent/PL2882446T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL13762204T 2012-08-09 2013-08-08 Terapia profilaktyczna i nutraceutyczna PL2882446T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB1214234.5A GB201214234D0 (en) 2012-08-09 2012-08-09 Prophylactic therapy
GBGB1214237.8A GB201214237D0 (en) 2012-08-09 2012-08-09 Novel therapeutic composition
PCT/GB2013/052132 WO2014023976A1 (en) 2012-08-09 2013-08-08 Prophylactic and nutraceutical therapy
EP13762204.9A EP2882446B1 (en) 2012-08-09 2013-08-08 Prophylactic and nutraceutical therapy

Publications (1)

Publication Number Publication Date
PL2882446T3 true PL2882446T3 (pl) 2018-10-31

Family

ID=49165779

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13762204T PL2882446T3 (pl) 2012-08-09 2013-08-08 Terapia profilaktyczna i nutraceutyczna

Country Status (7)

Country Link
US (3) US11103561B2 (pl)
EP (2) EP2882446B1 (pl)
DK (2) DK3295953T3 (pl)
ES (2) ES2676543T3 (pl)
HU (1) HUE038910T2 (pl)
PL (1) PL2882446T3 (pl)
WO (1) WO2014023976A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2882446B1 (en) 2012-08-09 2018-05-09 HAMLET Pharma AB Prophylactic and nutraceutical therapy
GB201707715D0 (en) * 2017-05-14 2017-06-28 Hamlet Pharma Ab Preperation of biologically active complexes
CN111494641B (zh) * 2020-04-22 2021-08-03 南开大学 肿瘤微环境响应性的表面电荷可反转纳米药物递送载体
CN113694194A (zh) * 2021-09-01 2021-11-26 四川力量科技有限公司 一种康复癌症的产品及其制作工艺
JP2025534430A (ja) 2022-10-03 2025-10-15 リネイン ファルマ アーベー 癌の治療または予防に使用するためのα－ラクトアルブミンおよび脂肪酸または脂質を含む複合体
GB202303177D0 (en) 2023-03-03 2023-04-19 Linnane Pharma Ab Method of predicting response to treatment
WO2025186107A1 (en) 2024-03-04 2025-09-12 Linnane Pharma Ab Therapy

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE182470T1 (de) 1994-08-16 1999-08-15 Hemant Sabharwal Multimeres alpha-lactalbumin enthaltende antibakterielle zusammensetzung
JP2001524491A (ja) * 1997-11-21 2001-12-04 カタリーナ・スヴァンボルイ ラクトアルブミン生産方法
GB0205347D0 (en) 2002-03-07 2002-04-24 Svanborg Catharina Biologically active complex
EP1727561A1 (en) 2004-02-26 2006-12-06 HAMLET Pharma AB Lactalbumin for inhibiting angiogenesis
EP2094309A2 (en) 2006-11-17 2009-09-02 Nya Hamlet Pharma AB Alpha-lactalbumin composition
NZ552316A (en) * 2006-12-22 2009-10-30 Fonterra Co Operative Group Dairy product and process
WO2008138348A1 (en) * 2007-05-09 2008-11-20 Nya Hamlet Pharma Ab Preparation of complexed lactalbumin
WO2009012784A2 (en) 2007-07-20 2009-01-29 Nya Hamlet Pharma Ab Methods for preparing cytotoxic complexes of emulsifier and fatty acid
US20110177224A1 (en) * 2008-03-03 2011-07-21 Daniel Perlman Stabilization of omega-3 fatty acids in oil-water emulsions
WO2010079362A1 (en) 2009-01-09 2010-07-15 Hamlet Pharma Ab Complex and production process
WO2010131237A1 (en) * 2009-05-13 2010-11-18 Agriculture And Food Development Authority (Teagasc) A process for producing a biologically active globular protein complex
ES2613986T3 (es) * 2010-11-24 2017-05-29 Hamlet Pharma Ab Complejo biológicamente activo y su preparación
EP2882446B1 (en) 2012-08-09 2018-05-09 HAMLET Pharma AB Prophylactic and nutraceutical therapy

Also Published As

Publication number Publication date
DK3295953T3 (da) 2021-01-25
HUE038910T2 (hu) 2018-12-28
US20240156916A1 (en) 2024-05-16
HK1249855A1 (en) 2018-11-16
DK2882446T3 (en) 2018-06-18
US11103561B2 (en) 2021-08-31
EP3295953B1 (en) 2020-10-21
US11865161B2 (en) 2024-01-09
US20150216945A1 (en) 2015-08-06
ES2676543T3 (es) 2018-07-20
EP3295953A1 (en) 2018-03-21
EP2882446B1 (en) 2018-05-09
US20190282669A1 (en) 2019-09-19
EP2882446A1 (en) 2015-06-17
WO2014023976A1 (en) 2014-02-13
ES2844874T3 (es) 2021-07-23

Similar Documents

Publication Publication Date Title
IL235826A0 (en) Diazaspirocycloalkane and azaspirocycloalkane
EP2854944A4 (en) LIGHT THERAPY DEVICES AND METHOD
HUE042637T2 (hu) Laminátumok és azok elõállítására szolgáló módszerek
SI3930322T1 (sl) Postopki in naprave za kodiranje
IL237926A0 (en) Combinations and their uses
GB201217439D0 (en) Combination therapy
EP2931140A4 (en) Tissue repair equipment and methods
PL2882446T3 (pl) Terapia profilaktyczna i nutraceutyczna
GB201207305D0 (en) Therapy
SG11201504482VA (en) Beta-hexosyl-transferases and uses thereof
EP2879707A4 (en) COMBINATION THERAPY
GB201301571D0 (en) Product and use
GB201213778D0 (en) Process and dressng
EP2809285A4 (en) HYPERBARE CHAMBER SYSTEM AND ASSOCIATED METHODS
GB201214234D0 (en) Prophylactic therapy
GB201222541D0 (en) Kiddibidet and pottibidet
IL218974A0 (en) Conaction bitwen coutch and playels
GB201202021D0 (en) Co-sleeper and breastfeeder
GB201218654D0 (en) Methods and product
GB201211961D0 (en) Methods and groups
GB201208845D0 (en) Methods and groups
GB201220504D0 (en) Product and use thereof
GB201214769D0 (en) Methodsa and peptides
GB201211543D0 (en) Combination therapy
GB201102221D0 (en) Inventions and therapy